Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision treatment for metastatic non-small cell lung cancer: A conceptual overview.

Cleveland Clinic journal of medicine - 1 Feb 2021

Lee Tristan, Clarke Jeffrey M, Jain Deepali, Ramalingam Sendhilnathan, Vashistha Vishal

Abstract excerpt

Recent developments in precision oncology have increased the complexity of diagnostic and therapeutic decisions. Here, we broadly review the field of precision oncology and discuss common mutational drivers in non-small cell lung cancer (NSCLC) that directly relate to the diagnosis, evaluation, and treatment of patients with metastatic disease.

Topics

Join the communities discussing this publication.

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Mutation
Precision Medicine

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33526466
DOI: 10.3949/ccjm.88a.19148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision treatment for metastatic non-small cell lung cancer: A conceptual overview.PMID 33526466Read ↗

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Paradigm shift in the management of metastatic Non-small Cell Lung CancerSemantic proximity Read ↗

Paradigm shift in the management of metastatic nonsmall cell lung cancer.Semantic proximity Read ↗

NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease.Semantic proximity Read ↗

Precision medicine in non-small cell lung cancer: Current applications and future directions.Semantic proximity Read ↗

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read ↗

Top advances of the year: Precision oncology.Semantic proximity Read ↗

The evolving paradigm of precision medicine in lung cancer.Semantic proximity Read ↗

Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future PerspectivesSemantic proximity Read ↗

BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.Semantic proximity Read ↗

Precision Oncology: Who, How, What, When, and When Not?Semantic proximity Read ↗

The Future of Precision Oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.